QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.

Prostate Cancer  : Wait and watch – or not?

(Dr. Catalona was a resource for this article. Courtesy of Globe and Mail, we are reprinting that portion of the article which relied on information from him.) One of the problems with active surveillance, Dr. Catalona said, is that there…

Read More

My Response: Two Recent PSA Screening Studies

The European Randomized Study of Screening for Prostate Cancer (ERSPC) reported that men who were assigned to be screened had a 20% lower death rate from prostate cancer than men not assigned to be screened. However, screening carried a high…

Read More
no cipro

Dr. Catalona's Position:  : Not Using Cipro

T he use of ciprofloxacin (Cipro) as a test to see whether an elevated PSA level will decrease is controversial. On one hand, clinical experience has shown that if the PSA decreases to previously low levels, it is possible to…

Read More

Subscribe to Quest

"*" indicates required fields

Email

This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*
Address*